Article Text

Download PDFPDF
Inflammatory myofibroblastic tumour of paranasal sinuses with fatal outcome: reactive lesion or tumour?
  1. N Gale1,
  2. N Zidar1,
  3. J Podboj2,
  4. M Volavšek1,
  5. B Luzar1
  1. 1Institute of Pathology, Medical Faculty, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia
  2. 2Department of Otorhinolaryngology and Cervicofacial Surgery, Clinical Centre, Zaloška 2, 1000 Ljubljana, Slovenia
  1. Correspondence to:
 Professor N Gale, Institute of Pathology, Medical Faculty, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia;


Inflammatory myofibroblastic tumours (IMTs) are clinicopathologically distinctive but biologically controversial entities, which have been described in the lungs, abdomen, retroperitoneum, and extremities, but rarely affect the head and neck region. IMT usually follows a benign clinical course after radical excision, but invasive, locally recurrent, and metastatic forms of abdominal and mediastinal IMT have also been described. This report describes a case of IMT of the paranasal sinuses with a fatal outcome. A 22 year old woman was admitted to hospital as a result of epistaxis. Computed tomography scan and magnetic resonance imaging showed an expansive process in the paranasal sinuses, extending into the nasal cavity, orbita, and endocranium. The tumour progressed despite several surgical procedures. Radiotherapy, corticosteroids, and chemotherapy were unsuccessful, and the patient died four years after diagnosis, as a result of extensive intracranial spread of the tumour. This is the first known case of an IMT of the head and neck region with a fatal outcome. It shows that the aggressive behaviour of IMTs is not limited to abdominal and mediastinal locations, and supports recent observations that at least a subset of IMTs represents true neoplasia rather than reactive myofibroblastic proliferation.

  • head and neck region
  • inflammatory myofibroblastic tumour
  • prognosis
  • pathogenesis
  • CT, computed tomography
  • IMT, inflammatory myofibroblastic tumour

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.